Martin Naley
Founder & Chief Strategy Office, Cure Forward

About Me

Martin Naley founded Cure Forward to solve critical needs in patient care and drug development. Patients had heard of precision medicine but didn’t know how to access tests or targeted therapies. Clinical trials were struggling to find patients. The opportunity became apparent for patients to engage in precision medicine and use their own data to find relevant and specific treatments. Martin incubated the idea at Apple Tree Partners, a healthcare venture capital firm, and the company was formed in 2014. Now the Cure Forward website is launched, helping hundreds of patients who are seeking options in their cancer care. Earlier in his career, Martin spent 15 years at Life Technologies, a manufacturer of the tools that power precision medicine.  There, he held various leadership positions including CEO Chief of Staff, Head of Medical Science Informatics, and VP Cell Culture Research. Martin holds a B.A. in Biological Sciences from Cornell and an M.B.A. from Yale.

At Medicine X 2015

Saturday, September 17 4:30 pm (LK 102)
How patients take control of their precision cancer care by accessing their own molecular profiling data
Advancements in technology and science are making precision medicine more possible every day. However, these innovations remain just out of reach for so many patients. We built a new company based on the... Read more
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search